Toth Financial Advisory Corp Biogen Inc. Transaction History

Toth Financial Advisory Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$256.56 - $292.34 $1,795 - $2,046	7 New	7 $1,000
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $8,061 - $10,359	-36 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$282.99 - $369.05 $10,187 - $13,285	36 New	36 $10,000
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $1,890 - $2,845	-8 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$220.06 - $304.07 $1,760 - $2,432	8 New	8 $2,000
Q1 2019 Apr 15, 2019	SELL	$216.71 - $338.96 $2,167 - $3,389	-10 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$293.51 - $383.83 $2,935 - $3,838	10 New	10 $4,000
Q1 2018 Apr 25, 2018	SELL	$260.13 - $367.91 $2,601 - $3,679	-10 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $3,076 - $3,445	10	10 $3,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.